2.A.117 The Proteobacterial Antimicrobial Compound Efflux (PACE) Family
Chlorhexidine, an antiseptic or disinfectant, is a membrane-active biocide. Hassan et al. 2013 examined the transcriptomic response of a representative nosocomial human pathogen, Acinetobacter baumannii, to chlorhexidine, to identify the primary chlorhexidine resistance elements. The most highly up-regulated genes encoded components of a major multidrug efflux system, AdeABC (TC# 2.A.6.2.40). The next most highly overexpressed gene under chlorhexidine stress was designated AceI. Orthologs of the aceI gene are conserved within the genomes of a broad range of proteobacterial species, but are also found in other bacterial phyla. Expression of aceI or its orthologs from several other γ- or β-proteobacterial species in Escherichia coli resulted in significant increases in resistance to chlorhexidine. Additionally, disruption of the aceI ortholog in Acinetobacter baylyi rendered it more susceptible to chlorhexidine. The AceI protein was localized to the membrane after overexpression in E. coli. This protein was purified, and binding assays demonstrated direct and specific interactions between AceI and chlorhexidine. Transport assays using [14C]-chlorhexidine showed that AceI mediates the energy-dependent efflux of chlorhexidine. It was later found to transport other drugs including benzalkonium, dequalinium, proflavine, and acriflavine. An E15Q AceI mutant with a mutation in a conserved acidic residue, although unable to mediate chlorhexidine resistance and transport, was still able to bind chlorhexidine. These data are consistent with AceI being an active chlorhexidine efflux protein and the founding member of a family of bacterial drug efflux transporters, structurally similar to the DMT superfamily (2.A.7).
The generalized transport reaction catalyzed by AceI is:
Chlorhexidine (in) → chlorhexidine (out)